|
CLCC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.594200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.823400E-01 |
| Normal-vs-Stage2 |
6.479400E-01 |
| Normal-vs-Stage3 |
5.907200E-01 |
| Normal-vs-Stage4 |
8.449600E-01 |
| Stage1-vs-Stage2 |
4.644600E-01 |
| Stage1-vs-Stage3 |
3.572400E-01 |
| Stage1-vs-Stage4 |
7.479400E-01 |
| Stage2-vs-Stage3 |
9.395200E-01 |
| Stage2-vs-Stage4 |
9.941600E-01 |
| Stage3-vs-Stage4 |
9.679600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.153400E-01 |
| Normal-vs-AfricanAmerican |
7.426600E-01 |
| Normal-vs-Asian |
2.548200E-01 |
| Caucasian-vs-AfricanAmerican |
8.786800E-01 |
| Caucasian-vs-Asian |
5.548200E-01 |
| AfricanAmerican-vs-Asian |
5.668400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.986000E-01 |
| Normal-vs-Female |
1.756770E-03 |
| Male-vs-Female |
3.84960000000545E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.665600E-01 |
| Normal-vs-Extreme_Weight |
2.798200E-01 |
| Normal-vs-Obese |
3.310600E-01 |
| Normal-vs-Extreme_Obese |
6.413400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.340600E-01 |
| Normal_Weight-vs-Obese |
5.596200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.160000E-01 |
| Extreme_Weight-vs-Obese |
6.723600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.926400E-01 |
| Obese-vs-Extreme_Obese |
3.569000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.408010E-01 |
| Normal-vs-Age(41-60Yrs) |
2.644000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.401600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.500600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.499400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.600100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.040400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.191900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.099000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.748000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.019600E-01 |
| Normal-VS-Type2 PRCC |
8.510000E-01 |
| Normal-VS-KIRP CIMP |
2.606000E-01 |
| Normal-VS-Unclassified PRCC |
5.167500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.404000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.054200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.481600E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.319430E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.848000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.964000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.682800E-01 |
| Normal-vs-N1 |
2.090400E-01 |
| Normal-vs-N2 |
2.975400E-01 |
| N0-vs-N1 |
1.301790E-01 |
| N0-vs-N2 |
2.860600E-01 |
| N1-vs-N2 |
1.498830E-01 |
|
|
